DexCom (DXCM) Competitors

Medtronic (NYSE:MDT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk, community ranking and earnings.

Which has stronger earnings & valuation, MDT or DXCM?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$32.36B	3.55	$3.68B	$3.29	27.24
DexCom	$4.03B	8.60	$576.20M	$1.43	62.10

Which has more risk & volatility, MDT or DXCM?

Medtronic has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in MDT or DXCM?

82.1% of Medtronic shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.2% of Medtronic shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts rate MDT or DXCM?

Medtronic presently has a consensus target price of $95.00, indicating a potential upside of 5.99%. DexCom has a consensus target price of $99.06, indicating a potential upside of 11.56%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	1 Sell rating(s)	9 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.38
DexCom	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.94

Does the media favor MDT or DXCM?

In the previous week, Medtronic had 63 more articles in the media than DexCom. MarketBeat recorded 105 mentions for Medtronic and 42 mentions for DexCom. DexCom's average media sentiment score of 1.03 beat Medtronic's score of 0.96 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	57 Very Positive mention(s)	6 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	26 Very Positive mention(s)	5 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MDT or DXCM more profitable?

DexCom has a net margin of 14.29% compared to Medtronic's net margin of 12.83%. DexCom's return on equity of 30.14% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	12.83%	14.07%	7.70%
DexCom	14.29%	30.14%	10.11%

Does the MarketBeat Community prefer MDT or DXCM?

Medtronic received 610 more outperform votes than DexCom when rated by MarketBeat users. Likewise, 75.48% of users gave Medtronic an outperform vote while only 71.75% of users gave DexCom an outperform vote.

Company	Underperform	Outperform
Medtronic	Outperform Votes 1588 75.48%	Underperform Votes 516 24.52%
DexCom	Outperform Votes 978 71.75%	Underperform Votes 385 28.25%

Summary

DexCom beats Medtronic on 13 of the 19 factors compared between the two stocks.